Vinva Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Vinva Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$57.7M	Buy	965,241 +26,900	+3%	+$1.57M	0.71%	23
2025 Q4	$50.9M	Buy	938,341 +353,835	+61%	+$17M	0.63%	30
2025 Q3	$25.8M	Buy	584,506 +341,246	+140%	+$15.9M	0.5%	44
2025 Q2	$11.3M	Buy	243,260 +138,135	+131%	+$6.78M	0.29%	86
2025 Q1	$6.31M	Sell	105,125 -8,810	-8%	-$514K	0.25%	106
2024 Q4	$6.39M	Sell	113,935 -18,166	-14%	-$1.02M	0.24%	97
2024 Q3	$6.73M	Buy	132,101 +17,231	+15%	+$808K	0.28%	86
2024 Q2	$4.77M	Buy	114,870 +29,472	+35%	+$1.32M	0.24%	101
2024 Q1	$4.63M	Buy	85,398 +5,723	+7%	+$292K	0.26%	97
2023 Q4	$4.08M	Buy	79,675 +2,352	+3%	+$123K	0.28%	88
2023 Q3	$4.5M	Buy	77,323 +925	+1%	+$56.7K	0.42%	55
2023 Q2	$4.89M	Buy	76,398 +3,593	+5%	+$241K	0.42%	55
2023 Q1	$4.97M	Buy	+72,805	New	+$5.14M	0.41%	63

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vinva Investment Management's BMY Position: Q1 2026 in Review

Vinva Investment Management increased its Bristol-Myers Squibb (BMY) stake by 2.9% in Q1 2026, buying an estimated $1.57M and bringing the position to 965,241 shares worth $57.7M. The position accounts for 0.71% of the portfolio, ranked #23.

Vinva Investment Management first reported a position in BMY in Q1 2023 and has held it in 13 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Vinva Investment Management held 965,241 shares of Bristol-Myers Squibb worth $57.7M as of Q1 2026.
Vinva Investment Management bought 26,900 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.57M.
Bristol-Myers Squibb made up 0.71% of Vinva Investment Management's portfolio in Q1 2026, its #23 holding.
Vinva Investment Management first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 13 quarters since.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.